(Q42541303)

English

Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells

scientific article published on April 1998

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

(2S,1'R,2'S)-loxoprofen trans-alcohol

1 reference

ChEBI release 2020-05-28

author name string

Kawai S

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Nishida S

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Kato M

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Furumaya Y

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Okamoto R

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Koshino T

6

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Mizushima Y

7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

347

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

87-94

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Inducible cyclooxygenase (COX-2): a safer therapeutic target?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Clinical implications of selective cyclooxygenase-2 inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

NSAIDs, Cox-2 inhibitors, and the gut

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900078-8

7 January 2021

Identifiers

10.1016/S0014-2999(98)00078-8

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42541303&oldid=1961251388"